Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.
Read More

Iovance Biotherapeutics Announces Clinical Data For LN-145 ; Showed 21.4% Overall Response Rate In Relapsed/Refractory Metastatic Non-Small Cell Lung Cancer Patients Following One Or More Prior Systemic Therapies Including Immunotherapy

 Iovance Biotherapeutics, Inc. (NASDAQ:IOVA), a late-stage biotechnology company developing novel T cell-based cancer immunotherapies, today announced clinical data for its tumor infiltrating lymphocyte (TIL)

IOVA

Read More

50 Biggest Movers From Yesterday

Gainers MoSys, Inc. (NASDAQ: MOSY) shares jumped 44.1% to settle at $5.46 on Wednesday. Lianluo Smart Limited (NASDAQ: LLIT) gained 24.6% to settle at $9.22.

ADXS